Literature DB >> 33456181

Hiatal hernia repair and magnetic sphincter augmentation to treat laryngopharyngeal reflux aiding the prevention of recurrent laryngeal cancer.

Madeline Smoot1, Marc A Ward1,2,3, Lindsey Arviso4, Christine E Sanchez3,5, Steven G Leeds1,2,3.   

Abstract

Laryngopharyngeal reflux (LPR) is a difficult disease to treat and can result in mucosal injury in the pharynx and larynx. This typically results in symptoms such as cough, hoarseness, and globus sensation, but the manifestation of cancer is a possibility. We present a patient with a squamous cell cancer of the larynx who was diagnosed with gastroesophageal reflux disease (GERD) and found to have LPR. The cancer was treated locally and GERD was eradicated with magnetic sphincter augmentation. After 15 months of follow-up, there was no residual cancer. This case highlights the role that untreated LPR may play in patients' risk of developing laryngeal cancer.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  Gastroesophageal reflux disease; hiatal hernia repair; laryngopharyngeal reflux; magnetic sphincter augmentation; squamous cell carcinoma

Year:  2020        PMID: 33456181      PMCID: PMC7785177          DOI: 10.1080/08998280.2020.1818167

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

1.  Optimal treatment of laryngopharyngeal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Edoardo Savarino; Andrea Nacci; Salvatore Osvaldo Romeo; Massimo Bellini; Vincenzo Savarino; Bruno Fattori; Santino Marchi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

2.  Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.

Authors:  Jean-Paul Galmiche; Jan Hatlebakk; Stephen Attwood; Christian Ell; Roberto Fiocca; Stefan Eklund; Göran Långström; Tore Lind; Lars Lundell
Journal:  JAMA       Date:  2011-05-18       Impact factor: 56.272

3.  Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.

Authors:  Reginald Bell; John Lipham; Brian Louie; Valerie Williams; James Luketich; Michael Hill; William Richards; Christy Dunst; Dan Lister; Lauren McDowell-Jacobs; Patrick Reardon; Karen Woods; Jon Gould; F Paul Buckley; Shanu Kothari; Leena Khaitan; C Daniel Smith; Adrian Park; Christopher Smith; Garth Jacobsen; Ghulam Abbas; Philip Katz
Journal:  Gastrointest Endosc       Date:  2018-07-18       Impact factor: 9.427

4.  20 years later: laparoscopic fundoplication durability.

Authors:  Ben Robinson; Christy M Dunst; Maria A Cassera; Kevin M Reavis; Ahmed Sharata; Lee L Swanstrom
Journal:  Surg Endosc       Date:  2014-12-09       Impact factor: 4.584

5.  Long-term patient outcomes after laparoscopic anti-reflux procedures.

Authors:  Anton Simorov; Ajay Ranade; Rachel Jones; Carl Tadaki; Valerie Shostrom; Eugene Boilesen; Dmitry Oleynikov
Journal:  J Gastrointest Surg       Date:  2014-01       Impact factor: 3.452

6.  Magnetic sphincter augmentation is an effective treatment for atypical symptoms caused by gastroesophageal reflux disease.

Authors:  Marc A Ward; Ahmed Ebrahim; Jeffrey Kopita; Lindsay Arviso; Gerald O Ogola; Brittany Buckmaster; Steven G Leeds
Journal:  Surg Endosc       Date:  2019-12-02       Impact factor: 4.584

7.  The role of laryngopharyngeal reflux as a risk factor in laryngeal cancer: a preliminary report.

Authors:  Kyung Tae; Bong Joon Jin; Yong Bae Ji; Jin Hyeok Jeong; Seok Hyun Cho; Seung Hwan Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-05-31       Impact factor: 3.372

Review 8.  Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux.

Authors:  C Liu; H Wang; K Liu
Journal:  Braz J Med Biol Res       Date:  2016-07-04       Impact factor: 2.590

9.  Laryngopharyngeal Reflux Disease - LPRD.

Authors:  Nizama Salihefendic; Muharem Zildzic; Emir Cabric
Journal:  Med Arch       Date:  2017-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.